FULGENT GENETICS, INC. Property, Plant and Equipment, Gross
FULGENT GENETICS, INC. (FLGT) had Property, Plant and Equipment, Gross of $177.36 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-07-30
- 2026-06-30: Property, Plant and Equipment, Gross $177.36M.
- 2026-03-31: Property, Plant and Equipment, Gross $177.65M.
- 2025-12-31: Property, Plant and Equipment, Gross $170.49M.
- 2025-09-30: Property, Plant and Equipment, Gross $166.06M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $177.36M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $177.65M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $170.49M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $166.06M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $168.96M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $161.94M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $157.26M 10-K · filed 2026-02-27 |
| 2024-09-30 | $155.92M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $138.81M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $133.51M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $135.10M 10-K · filed 2025-02-28 |
| 2023-09-30 | $132.37M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $137.22M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $125.22M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $124.63M 10-K · filed 2024-02-28 |
| 2022-09-30 | $117.77M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $115.73M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $91.84M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $81.92M 10-K · filed 2023-02-28 |
| 2021-09-30 | $77.31M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $65.83M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $59.83M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $51.12M 10-K · filed 2022-02-28 |
| 2020-09-30 | $27.20M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $15.12M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $14.26M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $13.96M 10-K · filed 2021-03-08 |
| 2019-09-30 | $13.84M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $12.87M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $12.47M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $12.33M 10-K · filed 2020-03-13 |
| 2018-09-30 | $12.20M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $12.17M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $11.14M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $11.04M 10-K · filed 2019-03-22 |
| 2017-09-30 | $9.78M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $9.59M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $8.36M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $8.28M 10-K · filed 2018-03-20 |
| 2016-09-30 | $6.81M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $3.37M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |